Serum antimüllerian hormone/müllerian-inhibiting substance appears to be a more discriminatory marker of assisted reproductive technology outcome than follicle-stimulating hormone, inhibin B, or estradiol
Top Cited Papers
- 30 November 2004
- journal article
- research article
- Published by Elsevier in Fertility and Sterility
- Vol. 82 (5) , 1323-1329
- https://doi.org/10.1016/j.fertnstert.2004.03.061
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Depletion of ovarian reserve in young women after treatment for cancer in childhood: detection by anti-Mullerian hormone, inhibin B and ovarian ultrasoundHuman Reproduction, 2003
- Anti-Müllerian Hormone Inhibits Initiation of Primordial Follicle Growth in the Mouse OvaryEndocrinology, 2002
- Antimüllerian hormone serum levels: a putative marker for ovarian agingFertility and Sterility, 2002
- Anti-Müllerian Hormone Attenuates the Effects of FSH on Follicle Development in the Mouse OvaryEndocrinology, 2001
- Serum müllerian-inhibiting substance levels during normal menstrual cyclesFertility and Sterility, 2000
- Developmental expression of a candidate müllerian inhibiting substance type II receptor.Endocrinology, 1996
- Ontogeny of Reproductive Abnormalities Induced by Deregulation of Anti-Müllerian Hormone Expression in Transgenic MiceBiology of Reproduction, 1995
- An Enzyme Linked Immunoassay for Anti-Müllerian Hormone: A New Tool for the Evaluation of Testicular Function in Infants and ChildrenJournal of Clinical Endocrinology & Metabolism, 1990
- An Immunoassay to Detect Human Mullerian Inhibiting Substance in Males and Females during Normal Development*Journal of Clinical Endocrinology & Metabolism, 1990
- Production of Anti-Müllerian Hormone: Another Homology between Sertoli and Granulosa CellsEndocrinology, 1984